DJIA 16,976.53 -6.06 -0.04%
NASDAQ 4,449.12 4.21 0.09%
S&P 500 1,975.21 -3.70 -0.19%
market minute promo

INTREXON CORP (NYSE: XON)



company name or ticker

Roundtable: What Could Be 2014's Twitter?

Twitter was one of the biggest investing stories of 2013. Which company will dominate 2014? Our top analysts share their thoughts, including looks at Intrexon and SolarCity.

Is There Still Room To Profit With Halozyme?

UPDATE: Intrexon to Acquire Medistem for $26M

OvaScience, Intrexon Collaborate on OvaScience's OvaTure Technology for Infertility Treatments

Why Halozyme Therapeutics Inc. Shares Jumped

Halozyme shares jump after announcing who will become its next CEO.

Synthetic Biologics, Intrexon Initiate Development of Novel Biologics for a Subset of Patients Suffe

Synthetic Biologics, Intrexon Initiate Development of Novel Biologics for a Subset of Patients Suffering from IBS

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Mel

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Melanoma

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12

In Insider Trading, Purchases by GlaxoSmithKline and Noted Biotech Investor Randal Kirk

Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape